1. Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapy;Nguyen;J Nucl Med,2004
2. Metabolic radiotherapy for gastroenteropancreatic endocrine tumors using radiolabeled somatostatin;Borson-Chazot;Ann Endocrinol,2006
3. Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues;Kwekkeboom;Hematol Oncol Clin North Am,2007
4. Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs;de Jong;J Nucl Med,2005
5. Rolleman EJ, Kooij PP, de Herder WW, Valkema R, Krenning EP, de Jong M. Somatostatin receptor subtype 2-mediated uptake of radiolabeled somatostatin analogues in the human kidney. Eur J Nucl Med Mol Imaging (in press).